Kun Cheng

Dr. Kun Cheng is a Curators' Distinguished Professor in the School of Pharmacy at the University of Missouri-Kansas City. His research focuses on developing novel drug delivery systems for cancer, Alzheimer's disease, and liver conditions, with particular expertise in nanomedicine, RNAi therapeutics, and targeted delivery approaches.

Research highlights:

• Peptide-based cancer immunotherapy and checkpoint inhibitors
• Nanoparticle systems for siRNA and drug delivery
• Therapeutic targeting of the blood-brain barrier
• Liver fibrosis treatment strategies

Awards and honors:

• AAPS Fellow (2020)
• AIMBE Fellow (2021)
• AAPS New Investigator Award (2011)
• Multiple UMKC teaching and research awards

Recent publications demonstrate innovations in pancreatic cancer nanotherapy, tumor-activated immunotherapy, and advanced delivery systems for genetic medicines.